Omar M. A. El‐Agnaf

Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease

Omar M. A. El‐Agnaf, Sultan A. Salem, Katerina E. Paleologou et al. · The FASEB Journal · 2006 · 700 citations

Pathology, Soluble Aggregates, Neurochemical Biomarkers +19

α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma

Omar M. A. El‐Agnaf, Sultan A. Salem, Katerina E. Paleologou et al. · The FASEB Journal · 2003 · 576 citations

Neurodegenerative Diseases, Medicine, Conditioned Culture Media +13

α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer

Bruno Fauvet, Martial Mbefo, Mohamed-Bilal Fares et al. · Journal of Biological Chemistry · 2012 · 556 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Neurobiology Of Disease +15

Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease

Takahiko Tokuda, M.M. Qureshi, Mustafa T. Ardah et al. · Neurology · 2010 · 512 citations

Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease

Takahiko Tokuda, Sultan A. Salem, David Allsop et al. · Biochemical and Biophysical Research Communications · 2006 · 430 citations

Neurodegenerative Diseases, Aged Individuals, Neurobiology Of Disease +12